|
|
|
Symbols |
Recent Price |
Market Cap |
Notes
|
|
ABIO |
3.38 |
???? |
This is just an example of what can happen to a biotech company after a
trial failure. Long way to go! |
|
ACAD |
1.97 |
72M |
Dead stock for a while, but it still have enough cash to stay alive for
another year. |
|
ACHN |
1.44 |
40M |
HIV, Bacteria Infections. 1 in P2 and 3 in P1. Lift off soon. Huge
potential. |
|
ACUR |
5.96 |
256M |
FDA DECISION PENDING. Pass or Fail? Head or Tail? |
|
ADLR |
1.76 |
82M |
Cash per share is higher than stock price.
Great Buy out candidate.
Pain Management drugs |
|
AEZS |
0.90 |
55M |
FDA decision Nov. 09. |
|
AFFX |
8.63 |
600M |
Medical Equipment. Chart shows cup and handle forming. Poised to
break out. |
|
AGEN |
2.15 |
190M |
P2. Cancer Vaccine. Long shot. This could be a story stock some day but
which way? |
|
AKRX |
1.32 |
110M |
Diagnostic Substances .
Price/Sale: Only 1. Under-valued!!!! Strong buy |
|
ALKS |
9.51 |
900M |
|
|
ALTH |
7.69 |
799M |
|
|
ALTU |
0.32 |
10M |
Company is in a nine line bind. Only RODM can bring this patient back to
life in the blink of an eye. |
|
ALXA |
2.77 |
96M |
Central nervous system. Six products in pipe line. One complete P3.
|
|
AMLN
|
12.53 |
1.78B |
800M+ Sale . Diabetes, obesity |
|
AMRI |
8.00 |
253M |
Contract service. Near 52 week low. |
|
ANDS |
2.73 |
101M |
Hepatitis C, cancer... |
|
ANIK |
6.73 |
77M |
Money making
company. Good execution. Good pipe line. Good fortune. |
|
APPA
|
0.82 |
27M |
**** P3 completed. Can explode any minute. |
|
ARIA
|
2.62 |
285M |
Cancer |
|
ARNA
|
5.30 |
490M |
BIG NEWS OCTOBER 2009 HIGH
RISK |
|
ARQL
|
5.49 |
245M |
Cancer |
|
ARRY
|
2.85 |
135M |
Cancer, inflammatory, diabetes. P1, P2 |
|
ARYX
|
3.40 |
93M |
Cancer, |
|
ATHX |
0.96 |
18M |
At this price, ATHX stock is less than its cash per share. Stem
cell. |
|
AVGN
|
1.30 |
45M |
Being acquired. |
|
AVII
|
2.05 |
175M |
Antisense and cancer immunoherapy technology |
|
AVNR |
2.21 |
173M |
P3 completed. |
|
BCRX
|
10.45 |
410M |
Cancer, viral infection, immune system... Rich pipe line. Roll over,
Tami |
|
BDSI |
4.80 |
99M |
1 approved. 1 P2. 1P1 |
|
BFRM
|
2.91 |
134M |
Medical Appliances &
Equipment. Profit trend looks good. Positive bottom line will drive
stock higher. |
|
BFRM
|
5.20 |
123M |
Diabetes, P3 |
|
BJGP
|
4.11 |
174M |
China market. Over-the counter products.Profitable. |
BNVI
Bionovo |
0.89 |
68M |
Women health and cancer.
1 IND, 1on P1 and 1 on P2. Very promising. |
|
BPAX
|
1.91 |
64M |
Female sexual Health |
|
CADX
|
10.50 |
538M |
1 candidate. 4 P3: Pain, fever.
High Valuation. |
|
CAPS
|
0.82 |
36M |
Peptides. Cash per share is higher than stock price. No debt.
Very low volume |
|
CERS
|
2.09 |
70M |
Blood Equipment |
|
CHTP |
6.44 |
215M |
P1, P2 |
|
CLDX
|
5.34 |
85M |
Cancer Vaccines |
|
CLSN
|
4.44 |
45M |
Oncology |
|
CLZR
|
1.88 |
|
Bought out by Syneron at 50% premium. !!!!! |
|
CMED |
15 |
488M |
Chinese Medical Technologies. |
|
CRGN
|
1.37 |
79M |
Cancer. Long shot. Amazing story: From one-eyed sheep to cancer
cure |
|
CRIS |
2.22 |
147M |
Cancer |
CRME
Cardiome Pharma Corp |
4.50 |
288M |
P3 Completed |
|
CRTX |
7.25 |
180M |
Respiratory Acquisition. Money making, bread and butter business. |
|
CRXX |
1.56 |
53M |
Rich pipeline. An easy double with potential to go much higher.
Merger could bring $5 a share |
|
CRY |
8.39 |
238M |
Distribution of implantable human tissues |
CTIC
Cell Therapeutics |
1.44 |
760M |
A story stock. Keep hope alive! Market cap is way too high!!! |
|
CUTR |
8.93 |
|
|
|
CVM |
1.36 |
203M |
Cancer Vaccine. P3 |
|
CXM |
1.76 |
83M |
Bone, tissue growth, repair, cardiovascular, P2 completed 07/09. Update
pending. **************** |
|
CYCC
|
1.00 |
25M |
Cancer. |
|
CYPB |
7.92 |
|
|
|
CYTK |
3.20 |
|
|
|
CYTR |
1.23 |
135M |
P1, P2. CYTR owns 39% of RXII |
|
DARA |
0.49 |
16M |
2 diabetes and psoriasis, 2 products with IND
********************* |
|
DCGN |
0.53 |
33M |
DNA-based diagnostic tests.
****** |
|
DCTH |
3.62 |
|
|
|
DDSS |
1.46 |
83M |
Pain Management. Anti depression. FDA decision pending. |
|
DEPO |
3.25 |
|
|
|
DRRX |
2.47 |
|
|
|
DSCO |
0.86 |
103M |
FDA Meeting Sep. 29th, 2009. |
|
DUSA |
1.08 |
26M |
Dermatology. Has own products. Stock at 5 year low. |
|
DVAX |
2.22 |
88M |
Influenza, Hepatitis vaccines.P3 pending |
|
DYAX |
4.12 |
298M |
oncology and inflammatory indications |
|
ENMD |
0.45 |
39.5M |
Cancer, Inflammation. |
|
ENZN |
7.74 |
|
|
|
EXEL |
6.27 |
|
|
|
FLML |
9.52 |
|
|
|
GERN |
7.21 |
|
|
|
GNBT |
0.90 |
163M |
Diabetis, others... First IND approval September 09. Possible Block Buster!!!
Listen: GNBT at Rodman |
GNVC
Genvec |
0.75 |
76M |
Cancer, vaccines. Phase II/III ; P3 . Huge potential |
|
GTXI |
9.95 |
|
|
|
HALO |
7.54 |
|
|
|
HEB |
2.00 |
253M |
Flu Vaccine, etc... Stock spiked 3 times over 50% each time, pulled back
all 3 times in 2009. Last time was in July 09. It could spike
again, but when? Market cap is high, but still cheaper than NVAX |
|
HEPH |
0.62 |
18M |
Hormones . Cancer. Diabetes. |
|
IDIX |
3.08 |
|
|
IAH
Antaeres |
1.08 |
85M |
Needle-free injection system. Skin gel...2 products in market, 2
in P3, 3 in P2, 3 in P1 |
|
ICGN |
1.18 |
55M |
Epilepsy, Pain, Asthma. P1, P2a |
|
IDIX |
3.08 |
|
|
|
IDRA |
7.42 |
|
|
|
IMGN |
7.44 |
|
|
|
IMMU |
6.35 |
477M |
Miss Piggy ! Hot air !
|
|
INCY |
6.86 |
|
|
|
INFI |
6.72 |
|
|
|
INHX |
1.18 |
51M |
Anti infection. Hepatitis C, HIV, herpes... . Great
potential here!!!! |
|
INSM |
0.87 |
111M |
Protein drugs. P3. |
|
IPXL |
7.99 |
|
|
|
ISR |
1.10 |
25M |
Isotope-based medical products to treat cancers |
|
ISPH |
6.22 |
|
|
|
ISTA |
5.70 |
|
|
|
ITMN |
15.37 |
|
|
|
JAV |
1.76 |
107M |
Pain Management |
|
JAZZ |
10.28 |
320M |
One of my home runs. JAZZ is rocking and actually
making money . Going higher |
|
LGND |
2.43 |
275M |
Critical unmet medical needs. Lots of things going. P1, 2, 3. |
|
LXRX |
1.55 |
213M |
|
|
MAPP |
10.00 |
|
|
|
MAXY |
7.07 |
|
|
|
MBLX |
10.77 |
|
|
|
MBRK |
1.11 |
95M |
|
|
MDCO |
11.15 |
|
|
|
MDCO |
11.15 |
|
|
|
MEDQ |
6.91 |
259M |
Medical Transcript software. Should do well with Obama's
healthcare plan. |
|
MITI |
7.25 |
|
|
|
MNKD |
9.04 |
937M |
Bloated.
GNBT is much much much better. |
|
MNOV |
6.79 |
|
|
|
MNTA |
9.88 |
383M |
Yawn Yawn Yawn. Market performed at best. |
|
MSHL |
0.70 |
51M |
Cancer. P1, P2, P3 |
|
MTXX |
5.78 |
|
|
|
MYRX |
4.47 |
|
|
|
NABI |
3.23 |
|
|
|
NBIX |
3.03 |
|
|
|
NGSX |
7.84 |
|
|
|
NKTR |
8.38 |
|
|
|
NPSP |
4.42 |
|
|
|
NSPH |
7.64 |
|
|
|
NTII |
0.90 |
24M |
Two products on P3.Stock is trading at cash value. This is a steal.
Dissolution in progress Sept 09 |
|
NURO |
3.03 |
43M |
Medical Equipment |
|
NVAX |
6.10 |
553M |
If NVAX can manage to double in price, it would be a billion
dollar bloated pig. Full of hot air here!
I wouldn't argue with the analysts at RODM
!!!! |
|
NVGN |
2.75 |
|
|
|
NXXI |
0.15 |
11M |
45M revenue!
$$$$$$$$$$$$$$$$$$!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! |
|
OCLS |
2.87 |
66M |
Skin Gel |
|
OMPI |
9.53 |
|
|
|
ONTY |
5.60 |
|
|
|
OPXA |
5.66 |
|
|
|
ORCH |
1.62 |
51M |
DNA Testing Service.56M revenues, but losing money. |
|
OREX |
8.20 |
|
|
|
ORXE |
0.60 |
4.05M |
This used to be Gene Logic. A cheap stock is cheap for some reasons and
can be cheaper. |
|
OSTE |
4.29 |
77M |
Biologic products for orthopedic, spinal, trauma, |
|
OSIR |
8.03 |
|
|
|
OSUR |
2.82 |
127M |
Medical Instruments &
Supplies |
|
OXGN |
1.42 |
89M |
P1. Cancer |
|
PCYC |
1.70 |
47M |
P1. Cancer |
|
PDLI |
8.81 |
|
|
|
PGNX |
5.31 |
|
|
|
POZN |
6.34 |
|
|
|
PPHM |
0.82 |
187M |
Anti bodies for cancer and viral infections. |
|
PRXL |
12.55 |
|
|
|
PTIE |
5.29 |
|
|
|
QCOR |
5.96 |
|
|
|
QGLY |
2.36 |
30M |
Manufacturing, marketing, distribution
Drug Delivery |
|
QLTI |
4.31 |
|
|
|
RIGL |
7.03 |
|
|
|
RPRX |
0.82 |
12.5M |
P2, P2a, P3 . Wow! Popped 31% 9/17/09 |
|
RXII |
2.83 |
46M |
Obesity, Diabetes. |
|
SCLN |
4.99 |
|
|
|
SCMP |
5.55 |
|
|
|
SGMO |
8.50 |
|
|
|
SIGA |
7.88 |
|
|
|
SLTM |
1.71 |
???? |
Medical Appliances &
Equipment |
|
SMMX |
6.48 |
|
|
|
SNMX |
3.66 |
|
|
|
SNTA |
2.75 |
|
|
|
SNTS |
3.17 |
|
|
|
SOMX |
2.45 |
60M |
Insomnia . NDA resubmitted June 4th, 2009. FDA decision expected by
December or early 2010. |
|
SPPI |
7.19 |
|
|
|
SSRX |
10.49 |
|
|
|
STEM |
1.68 |
181M |
Stem cell technology |
|
SUPG |
2.87 |
168M |
Cancer, tumor. P3. Lot of cash |
|
SVA |
9.43 |
400M |
China's vaccine maker. Flu is seasonal, and so is SVA. |
|
TELK |
0.91 |
48M |
Small molecule drugs: Cancer, others |
|
THLD |
1.49 |
23M |
Cancer. P1/2 |
|
TOMO |
3.63 |
|
|
|
TRBN |
5.59 |
|
|
|
TRMS |
2.43 |
|
|
|
TTHI |
5.23 |
|
|
|
VICL |
5.02 |
|
|
|
VNDA |
12.52 |
|
|
|
VSCI |
1.40 |
52M |
Endoscope Medical Appliances
& Equipment |
|
VVUS |
11.80 |
825M |
P3 result announced 09/09/09.
Home run. Well done! Good job VVUS! Block Buster!!! |
|
WHRT |
4.45 |
59M |
Implantable ventricular assist devices (Artificial Heart Pump) . Almost
no sales, no profit, no....nothing!!! |
|
XOMA |
0.88 |
145M |
Definitely under-valued. Buy and Hold. |
|
XTNT.PK |
0.37 |
|
Medical Device. No sales. |
|
YMI |
1.61 |
90M |
Cancer. Popped 9/16 |
|
ZGEN |
6.42 |
443M |
ZymoGenetics, the pharmaceutical zombie |
